Browsing “June, 2020 | EVERSANA”

NHIS-Commissioned Study Finds Generic Medicines Used Less in South Korea Compared to OECD Countries

Country: SOUTH KOREA | Region: ASIA & SOUTH PACIFIC | Type: Policy | Keywords: #domesticproduction #drugsupply #genericdruguse #generics #krpia #nhis #oecd #pricecuts #regulation PRICENTRIC BRIEF: Head researcher Professor Lee Sang-won of the National Health Insurance Service (NHIS)-commissioned project, “Improvement of Drug Supply and Purchasing System,” has expressed support for South Korean health policy to lower generic drug prices and expand their use Generics in OECD countries comprise 70% of total […]

Merck’s Keytruda Secures Metastatic Colorectal Cancer Approval from FDA

Country: UNITED STATES | Region: NORTH AMERICA | Type: Drug Approval | Keywords: #fda #merck #msd #oncologycenterofexcellence #projectorbis #realtimeoncologyreview #rtor PRICENTRIC BRIEF: The U.S. Food and Drug Administration (FDA) has approved Merck’s Keytruda (pembrolizumab) as monotherapy for the first-line treatment of patients with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer Approval from the FDA is based on results from the Phase 3 KEYNOTE-177 trial […]

ICER’s 2020 Unsupported Price Increase Analysis Will Focus on 13 Drugs

Country: UNITED STATES | Region: NORTH AMERICA | Type: Cost Effectiveness | Keywords: #clinicalevidence #icer #prescriptiondrugs #pricechanges #priceincreases PRICENTRIC BRIEF: The Institute for Clinical and Economic Review (ICER) published its protocol for its upcoming “Unsupported Price Increase” (UPI) report in which the institute will examine significant price increases for prescription drugs and determine if new evidence is needed to support the increases ICER’s report will focus on up […]

UK Launches “Pioneering” Payment Scheme to Tackle AMR

Country: UNITED KINGDOM | Region: EUROPE | Type: Policy | Keywords: #amr #antibiotics #antimicrobialresistance #incentive #innovation #model #payment #subscription #uk PRICENTRIC BRIEF: In a world-first, the UK is testing a pioneering scheme to provide new antibiotics to NHS patients by offering to pay pharmaceutical companies upfront for their contributions As part of the project, the NHS is offering two contracts to pay pharmaceutical companies at the start of their work for access […]

Spain Must “Go Further, Bet on R&D, Innovation, Knowledge,” Says Farmaindustria President Sellés

Country: SPAIN | Region: EUROPE | Type: Policy | Keywords: #access #affordability #clinicaltrials #covid19 #farmaindustria #industry #investment #r&d #sns PRICENTRIC BRIEF: In its pharmaceutical industry proposals for economic and social reform, the National Trade Association of the Spanish-Based Pharmaceutical Industry (Farmaindustria) is requesting more investment in research and production in Spain Sellés explained that investment in R&D and innovation and public-private collaboration are crucial to be “faster in finding pharmacological and more […]

Japan Pharma Association Introduces Bold Policy Measures to Reform Sector

Country: JAPAN | Region: ASIA & SOUTH PACIFIC | Type: Policy | Keywords: #covid19 #drugsupply #innovation #jpma #marketentryrewards #mhlw #patientaccess #pharmasector #r&d #re-pricing #regulation #taxincentives #vaccines PRICENTRIC BRIEF: The Japan Pharmaceutical Manufacturers Association (JPMA) has proposed a new policy for economic and fiscal management and reform in Japan, which was mainly inspired by the effect of the coronavirus pandemic on the healthcare system and pharmaceutical industry in Japan The proposal first addresses the immediate need of […]

FDA Approves BMS’ Opdivo for Advanced ESCC After Chemotherapy

Country: UNITED STATES | Region: NORTH AMERICA | Type: Drug Approval | Keywords: #bms #escc #esophagealcancer #fda #priorityreview PRICENTRIC BRIEF: The U.S. Food and Drug Administration (FDA) has approved Bristol-Myers Squibb’s (BMS) immunotherapy Opdivo (nivolumab) for the treatment of adult patients with unresectable advanced, recurrent or metastatic esophageal squamous cell carcinoma (ESCC), following prior fluoropyrimidine- and platinum-based chemotherapy Approval from the U.S. regulator is based on results from […]

Greece Pharma Association Puts Forth 7 Pillars to Boost Sector

Country: GREECE | Region: EUROPE | Type: Policy | Keywords: #healthsystem #sfee PRICENTRIC BRIEF: The Hellenic Association of Pharmaceutical Companies (SFEE) has put forth a proposal consisting of seven pillars to lead to a sustainable and efficient health system and pharmaceutical sector in Greece The seven pillars address the pharmaceutical budget, the efficiency of the health system in Greece, clawback payments, patient access to innovation, […]

Canada Publishes Budget Impact Analysis Guidelines Under New PMPRB Amendments

Country: CANADA-ONTARIO | Region: NORTH AMERICA | Type: Policy | Keywords: #budgetimpactanalysis #cadth #guidelines #newdrug #pmprb #referencepricing #reimbursement PRICENTRIC BRIEF: The Government of Canada has published “Budget Impact Analysis Guidelines” for conducting pharmaceutical budget impact analyses for submission to public drug plans in Canada, as part of the new amendments to the Patented Medicine Prices Review Board (PMPRB) Budget impact analyses (BIAs) will focus on the financial impact of a […]

ICER Publishes Draft Evidence Review for Ulcerative Colitis – Pfizer, Janssen, Merck, AbbVie, and Takeda Impacted

The Institute for Clinical and Economic Review published their Draft Evidence report for what could be one of the biggest reviews of 2020. The review of Ulcerative Colitis (UC) impacts big players in Immunology – all of which will need to bring their A-Game to this class review. Due to COVID-19, the meeting will be […]